| Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526) |
|---|
| 09/18/1997 | WO1997033990A1 Regulatory element for interleukin-5 |
| 09/18/1997 | WO1997033979A1 Transgenic model of hepatitis c virus infection |
| 09/18/1997 | WO1997033977A1 Human t cell clone specific for rheumatoid arthritis |
| 09/18/1997 | WO1997033914A1 Methods for producing hemoglobin preparations and preparations obtainable thereby |
| 09/18/1997 | WO1997033913A1 Cytokine-receptor expressed in testis cells |
| 09/18/1997 | WO1997033912A2 Uses of gdnf and gdnf receptor |
| 09/18/1997 | WO1997033911A1 Persephin and related growth factors |
| 09/18/1997 | WO1997033910A1 Immunomodulatory peptides of vespid antigen 5 |
| 09/18/1997 | WO1997033909A2 Compounds and methods for immunotherapy and immunodiagnosis of prostate cancer |
| 09/18/1997 | WO1997033908A1 Lytic peptides |
| 09/18/1997 | WO1997033904A1 Death domain containing receptors |
| 09/18/1997 | WO1997033903A1 HUMAN MutY |
| 09/18/1997 | WO1997033902A1 Human tumor necrosis factor delta and epsilon |
| 09/18/1997 | WO1997033901A1 Smooth muscle cell lim protein |
| 09/18/1997 | WO1997033900A1 E2a-binding protein |
| 09/18/1997 | WO1997033899A1 Apoptosis inducing molecule i |
| 09/18/1997 | WO1997033898A1 Human 4-1bb receptor splicing variant |
| 09/18/1997 | WO1997033881A1 Bicyclic-aromatic compounds |
| 09/18/1997 | WO1997033618A1 Targeting macromolecular prodrugs to t lymphocytes |
| 09/18/1997 | WO1997033617A1 Fas ligand fusion proteins and their uses |
| 09/18/1997 | WO1997033615A2 Caprine arthritis-encephalitis virus provides immunoprotection against hiv-1 infection |
| 09/18/1997 | WO1997033613A1 Parasite-derived anti-inflammatory immunomodulatory protein |
| 09/18/1997 | WO1997033607A1 Orally-administered interferon-tau compositions and methods |
| 09/18/1997 | WO1997033605A1 Human occludin, its uses and enhancement of drug absorption using occludin inhibitors |
| 09/18/1997 | WO1997033603A1 Novel peptides which inhibit complement activation |
| 09/18/1997 | WO1997033602A1 Peptides with increased binding affinity for hla molecules |
| 09/18/1997 | WO1997033551A2 Compositions and methods for the diagnosis, prevention, and treatment of neoplastic cell growth and proliferation |
| 09/18/1997 | WO1997033466A1 Non-genetically modified mammal as a model for multiple sclerosis |
| 09/18/1997 | WO1997025351A3 INHIBITORS OF MAdCAM-1-MEDIATED INTERACTIONS AND METHODS OF USE THEREFOR |
| 09/18/1997 | WO1997025343A3 Antithrombotic agents and methods of use |
| 09/18/1997 | WO1997022695A3 Nucleotide sequences, proteins, drugs and diagnostic agents for treating cancer |
| 09/18/1997 | WO1997007815A3 Pharmaceutical compositions for the nasal delivery of compounds useful for the treatment of osteoporosis |
| 09/18/1997 | DE19608813A1 Konjugat zur Beeinflussung von Wechselwirkungen zwischen Proteinen Conjugate for influencing protein-protein interactions |
| 09/18/1997 | DE19549420A1 Tumour necrosis factor-alpha and/or bacterial lipo-poly:saccharide removal |
| 09/18/1997 | CA2407668A1 Human bikunin |
| 09/18/1997 | CA2249742A1 Compounds and methods for immunotherapy and immunodiagnosis of prostate cancer |
| 09/18/1997 | CA2249182A1 Death domain containing receptors |
| 09/18/1997 | CA2249023A1 Human t cell clone specific for rheumatoid arthritis |
| 09/18/1997 | CA2249007A1 Parasite-derived anti-inflammatory immunomodulatory protein |
| 09/18/1997 | CA2248998A1 Inhibiting protein interactions |
| 09/18/1997 | CA2248978A1 Vectors based on recombinant defective viral genomes, and their use in the formulation of vaccines |
| 09/18/1997 | CA2248927A1 Smooth muscle cell lim protein |
| 09/18/1997 | CA2248782A1 Lytic peptides |
| 09/18/1997 | CA2248707A1 Clostridium perfringens vaccines |
| 09/18/1997 | CA2248684A1 Immunity to trypanosomatids species |
| 09/18/1997 | CA2248657A1 Peptides with increased binding affinity for hla molecules |
| 09/18/1997 | CA2248612A1 Recombinant adenoviral vectors for human tumour gene therapy |
| 09/18/1997 | CA2248549A1 Extracellular matrix signalling molecules |
| 09/18/1997 | CA2248539A1 Use of viral cis-acting post-transcriptional regulatory sequences to increase expression of intronless genes containing near-consensus splice sites |
| 09/18/1997 | CA2248537A1 Immunomodulatory peptides of vespid antigen 5 |
| 09/18/1997 | CA2248355A1 Human membrane antigen tm4 superfamily protein and dna encoding this protein |
| 09/18/1997 | CA2247888A1 Human bikunin |
| 09/18/1997 | CA2247805A1 Expression and secretion of heterologous polypeptides from caulobacter |
| 09/18/1997 | CA2247804A1 Vaccine compositions and methods useful in inducing immune protection against arthritogenic peptides involved in the pathogenesis of rheumatoid arthritis |
| 09/18/1997 | CA2247432A1 Targeting macromolecular prodrugs to t lymphocytes |
| 09/18/1997 | CA2246768A1 Uses of gdnf and gdnf receptor |
| 09/18/1997 | CA2225913A1 Persephin and related growth factors |
| 09/18/1997 | CA2221028A1 Non-genetically modified mammal as a model for multiple sclerosis |
| 09/17/1997 | EP0795606A1 Process for producing transformed cell |
| 09/17/1997 | EP0795605A1 Denatured low-density lipoprotein receptor |
| 09/17/1997 | EP0795562A1 Novel oxyntomodulin |
| 09/17/1997 | EP0795554A2 (Oxo-)xanthene derivatives, their preparation and their use as immunomodulators |
| 09/17/1997 | EP0795021A2 Retroviral delivery of full length factor viii |
| 09/17/1997 | EP0795017A1 Hippocampus-associated proteins, dna sequences coding therefor and uses thereof |
| 09/17/1997 | EP0795015A1 Plasmids suitable for il-2 expression |
| 09/17/1997 | EP0795014A1 Purified genes encoding mammalian cell surface antigens; proteins and antibodies |
| 09/17/1997 | EP0795013A1 Receptor for cell-binding domain of thrombospondins |
| 09/17/1997 | EP0795005A1 New e.coli mutant with suppressed organic acid production |
| 09/17/1997 | EP0794965A1 Factor vii fragment 82-128 and its use in blood-clotting disorders |
| 09/17/1997 | EP0794964A1 Interferon glycoprotein |
| 09/17/1997 | EP0794963A2 A method of identifying cftr-binding compounds useful for activating chloride conductance in animal cells |
| 09/17/1997 | EP0794962A1 Dna-binding factor ctcf |
| 09/17/1997 | EP0794960A1 An aglucone isoflavone enriched vegetable protein concentrate and process for producing |
| 09/17/1997 | EP0794959A1 Amino acids for making betides and methods of screening and making betide libraries |
| 09/17/1997 | EP0794824A1 Method and device for separating fibrin monomer from blood plasma |
| 09/17/1997 | EP0794797A1 Methods and devices for immunizing a host through administration of naked polynucleotides which encode antigenic peptides |
| 09/17/1997 | EP0634937B1 Vaccines containing non-ionic surfactant vesicles |
| 09/17/1997 | EP0582582B1 Process for detecting the differentiation and invasiveness of carcinoma cells |
| 09/17/1997 | EP0537280B1 Preparation and use of transfer factor |
| 09/17/1997 | CN1159831A Vaccines containing borrelia burgdorferi OSPG |
| 09/17/1997 | CN1159830A Immunomodulators |
| 09/17/1997 | CN1159829A 17q-linked breast and ovarian cancer susceptibility gene |
| 09/17/1997 | CN1159828A Process for manufacture of a modified collagen-induced platelet aggregation inhibitor pallidipin |
| 09/17/1997 | CN1159827A FLT-4 (fms-like tyrosine-kinase), FLT-15, variants thereof uses as growth factor inhibitors |
| 09/17/1997 | CN1159811A Isolated nucleic acid molecule coding for tumor rejection antigen precursor dage and uses thereof |
| 09/17/1997 | CN1159759A Compositions containing tumor rejection antigen precursors or tumor rejection antigens, and an adjuvant and/or growth factor |
| 09/16/1997 | US5668295 Protein involved in nicotine synthesis, DNA encoding, and use of sense and antisense DNAs corresponding thereto to affect nicotine content in transgenic tobacco cells and plants |
| 09/16/1997 | US5668272 Method for producing synthetic N-linked glycoconjugates |
| 09/16/1997 | US5668267 Polynucleotides encoding mammaglobin, a mammary-specific breast cancer protein |
| 09/16/1997 | US5668264 High affinity PDGF nucleic acid ligands |
| 09/16/1997 | US5668263 Conserved yeast nucleic acid sequences |
| 09/16/1997 | US5668256 Chimeric interleukin 5-receptor/immunoglobulin polypeptides |
| 09/16/1997 | US5668255 Hybrid molecules having translocation region and cell-binding region |
| 09/16/1997 | US5668254 Bioactive, oxidation resistance |
| 09/16/1997 | US5668158 Cyclic amino acid derivatives |
| 09/16/1997 | US5668110 Peptides and compounds that bind to the IL-5 receptor |
| 09/16/1997 | US5668109 Peptides for inhibiting pepsin release |
| 09/16/1997 | US5668108 Preparation of functional human factor VIII and pharmaceutical treatment therewith |
| 09/16/1997 | US5668107 Polypeptide bonded to extracellular matrix protein |
| 09/16/1997 | US5668106 Method and compositions for making ACSF and ACSF antagonists |